|
CLEC2D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.18278778069725E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.71080000458346E-08 |
| Normal-vs-Stage2 |
7.616900E-03 |
| Normal-vs-Stage3 |
1.602500E-04 |
| Normal-vs-Stage4 |
1.754310E-02 |
| Stage1-vs-Stage2 |
6.014600E-01 |
| Stage1-vs-Stage3 |
3.867000E-01 |
| Stage1-vs-Stage4 |
9.665800E-02 |
| Stage2-vs-Stage3 |
8.590200E-01 |
| Stage2-vs-Stage4 |
1.510250E-01 |
| Stage3-vs-Stage4 |
1.625560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.43579650577908E-11 |
| Normal-vs-AfricanAmerican |
2.09940000051034E-07 |
| Normal-vs-Asian |
4.199500E-03 |
| Caucasian-vs-AfricanAmerican |
3.288200E-01 |
| Caucasian-vs-Asian |
7.882400E-02 |
| AfricanAmerican-vs-Asian |
2.344300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8205993924123E-11 |
| Normal-vs-Female |
2.18140000507461E-08 |
| Male-vs-Female |
4.684600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.814820E-04 |
| Normal-vs-Extreme_Weight |
3.87230000287175E-08 |
| Normal-vs-Obese |
3.75839999999794E-05 |
| Normal-vs-Extreme_Obese |
1.915690E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.245400E-01 |
| Normal_Weight-vs-Obese |
9.501800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.846640E-01 |
| Extreme_Weight-vs-Obese |
7.588800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.852590E-01 |
| Obese-vs-Extreme_Obese |
1.739570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.35490000000316E-05 |
| Normal-vs-Age(41-60Yrs) |
5.33139976610641E-10 |
| Normal-vs-Age(61-80Yrs) |
5.75370000532871E-08 |
| Normal-vs-Age(81-100Yrs) |
7.273700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.513200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.039940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.232300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.522080E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.079400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.599400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.91110477337975E-11 |
| Normal-VS-Type2 PRCC |
4.586600E-04 |
| Normal-VS-KIRP CIMP |
7.202200E-03 |
| Normal-VS-Unclassified PRCC |
1.407730E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.507200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.830100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.552600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.731600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.591800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.004000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.08860000000733E-05 |
| Normal-vs-N1 |
9.85550000000002E-05 |
| Normal-vs-N2 |
8.228100E-04 |
| N0-vs-N1 |
2.453800E-02 |
| N0-vs-N2 |
8.488400E-01 |
| N1-vs-N2 |
3.729000E-01 |
|
|
